Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 792572, 6 pages
http://dx.doi.org/10.1155/2015/792572
Research Article

Pathfast Presepsin Assay for Early Diagnosis of Systemic Inflammatory Response Syndrome in Patients with Nephrolithiasis

Department of Urology, First Affiliated Hospital of Jiaxing Medical College, Jiaxing 314000, China

Received 16 October 2014; Revised 18 January 2015; Accepted 20 January 2015

Academic Editor: Kurt G. Naber

Copyright © 2015 Yan-song Hou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. Keddis and A. D. Rule, “Nephrolithiasis and loss of kidney function,” Current Opinion in Nephrology and Hypertension, vol. 22, no. 4, pp. 390–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Neisius and G. M. Preminger, “Stones in 2012: epidemiology, prevention and redefining therapeutic standards,” Nature Reviews Urology, vol. 10, no. 2, pp. 75–77, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. E. I. Kreydin and B. H. Eisner, “Risk factors for sepsis after percutaneous renal stone surgery,” Nature Reviews Urology, vol. 10, no. 10, pp. 598–605, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Eswara, A. Sharif-Tabrizi, and D. Sacco, “Positive stone culture is associated with a higher rate of sepsis after endourological procedures,” Urological, vol. 41, no. 5, pp. 411–414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Demirtas, Y. E. Yildirim, M. Sofikerim et al., “Comparison of infection and urosepsis rates of ciprofloxacin and ceftriaxone prophylaxis before percutaneous nephrolithotomy: a prospective and randomised study,” The Scientific World Journal, vol. 2012, Article ID 916381, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kumar, S. Bag, R. Ganesamoni, A. K. Mandal, N. Taneja, and S. K. Singh, “Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis,” Urological Research, vol. 40, no. 1, pp. 79–86, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Mariappan, G. Smith, S. A. Moussa, and D. A. Tolley, “One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study,” BJU International, vol. 98, no. 5, pp. 1075–1079, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Kibe, K. Adams, and G. Barlow, “Diagnostic and prognostic biomarkers of sepsis in critical care,” Journal of Antimicrobial Chemotherapy, vol. 66, supplement 2, pp. ii33–ii40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Sridharan and R. S. Chamberlain, “The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?” Surgical Infections, vol. 14, no. 6, pp. 489–511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Adib-Conquy and J.-M. Cavaillon, “Host inflammatory and anti-inflammatory response during sepsis,” Pathologie Biologie, vol. 60, no. 5, pp. 306–313, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. Balk, “Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?” Virulence, vol. 5, no. 1, pp. 20–26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Shirakawa, K. Naitou, J. Hirose, T. Takahashi, and S. Furusako, “Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients,” Clinical Chemistry and Laboratory Medicine, vol. 49, no. 5, pp. 937–939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Shozushima, G. Takahashi, N. Matsumoto, M. Kojika, Y. Okamura, and S. Endo, “Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome,” Journal of Infection and Chemotherapy, vol. 17, no. 6, pp. 764–769, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Sugie, K. Igami, K. Shoji et al., “Performance evaluation of the new rapid fertility assays in whole blood and plasma on PATHFAST,” Clinical Laboratory, vol. 57, no. 1-2, pp. 99–106, 2011. View at Google Scholar · View at Scopus
  15. Y. Okamura and H. Yokoi, “Development of a point-of-care assay system for measurement of presepsin (sCD14-ST),” Clinica Chimica Acta, vol. 412, no. 23-24, pp. 2157–2161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Yaegashi, K. Shirakawa, N. Sato et al., “Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis,” Journal of Infection and Chemotherapy, vol. 11, no. 5, pp. 234–238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Glück, J. Silver, M. Epstein, P. Cao, B. Farber, and S. M. Goyert, “Parameters influencing membrane CD14 expression and soluble CD14 levels in sepsis,” European Journal of Medical Research, vol. 6, no. 8, pp. 351–358, 2001. View at Google Scholar · View at Scopus
  18. G. Lucarelli, V. Mancini, V. Galleggiante et al., “Emerging urinary markers of renal injury in obstructive nephropathy,” BioMed Research International, vol. 2014, Article ID 303298, 7 pages, 2014. View at Publisher · View at Google Scholar
  19. R. C. Bone, R. A. Balk, F. B. Cerra et al., “Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992,” Chest, vol. 136, no. 5, article e28, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. L. Mehta, J. A. Kellum, S. V. Shah et al., “Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury,” Critical Care, vol. 11, no. 2, article R31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Margel, Y. Ehrlich, N. Brown, D. Lask, P. M. Livne, and D. A. Lifshitz, “Clinical implication of routine stone culture in percutaneous nephrolithotomy—a prospective study,” Urology, vol. 67, no. 1, pp. 26–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Ulla, E. Pizzolato, M. Lucchiari et al., “Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study,” Critical Care, vol. 17, no. 4, article R168, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Chenevier-Gobeaux, E. Trabattoni, M. Roelens, D. Borderie, and Y.-E. Claessens, “Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values?” Clinica Chimica Acta, vol. 427, pp. 34–36, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Dessì, G. Corsello, M. Stronati et al., “New diagnostic possibilities in systemic neonatal infections: metabolomics,” Early Human Development, vol. 90, supplement 1, pp. S19–S21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Palmiere and M. Augsburger, “Markers for sepsis diagnosis in the forensic setting: state of the art,” Croatian Medical Journal, vol. 55, no. 2, pp. 103–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Sandquist and H. R. Wong, “Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment,” Expert Review of Clinical Immunology, vol. 10, no. 10, pp. 1349–1356, 2014. View at Publisher · View at Google Scholar
  27. D. Mokart, M. Merlin, A. Sannini et al., “Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery,” British Journal of Anaesthesia, vol. 94, no. 6, pp. 767–773, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. K. L. Becker, R. Snider, and E. S. Nylen, “Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations,” Critical Care Medicine, vol. 36, no. 3, pp. 941–952, 2008. View at Publisher · View at Google Scholar · View at Scopus